About the technology
: Restoring Immune Balance
AffyXell Therapeutics Co., Ltd. is developing a novel cell & gene therapy based
on mesenchymal stem cell (MSC) to obstacle the diseases that come from imbalance
of immune system homeostasis.
Immunomodulation function by MSC is further increased with Affimer® platform,
restoring immunologic balance, and we will do the best we can to lead treating diseases
with new therapeutic approach that can resolve fundamental causes of intractable
diseases like immune rejection and autoimmune diseases.